AngioDynamics | ANGO - Gross Profit On Sales


AngioDynamics reported $44.78M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Accuray USD 41.89M 7.42M Dec/2024
AngioDynamics USD 44.78M 2.93M Sep/2025
Artivion USD 73.14M 1.25M Dec/2025
AtriCure USD 105.34M 4M Dec/2025
Boston Scientific USD 3.68B 136M Dec/2025
Edwards Lifesciences USD 1.23B 18.7M Dec/2025
ICU Medical USD 202.98M 2.1M Dec/2025
Inogen USD 41.34M 1.39M Sep/2024
J&J USD 16.6B 118M Dec/2025
Medtronic USD 5.41B 27M Dec/2025
Merit Medical Systems USD 195.35M 8.94M Dec/2025
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Orthofix International USD 153.28M 4.76M Dec/2025
Smiths GBP 430M 16M Dec/2022
Surmodics USD -11.54M 3.99M Sep/2024
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.45M 144.2M Dec/2025
Terumo JPY 153.19B 6.2B Dec/2025
Trinity Biotech USD 6.47M 1.59M Sep/2025